Nystatin mycelium

Flucloxacillin sodium compacted

Dsm Sinochem Pharmaceuticals provides wide range of semi-synthetic penicillins which includes flucloxacillin sodium compacted. Characteristics: granules obtained by means of dry compaction of the crystalline powder without adding any excipients. Application: the product is suitable for the manufacture of c...

Flucloxacillin sodium powder

Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes flucloxacillin sodium powder. Characteristics: a crystalline powder, hygroscopic. Application: the product is suitable for the manufacture of dry syrup formulation. The appropriate excipients should be added. Therape...

Nystatin micronized

Centrient Pharmaceuticals provides wide range of anti-fungals which includes nystatin micronized. Characteristics: a microfine crystalline powder. Application: the product is suitable for the manufacture of (extemporaneous) oral suspensions. Therapeutic category: polyene antibiotic with antifungal act...

Centrient Pharmaceuticals provides wide range of anti-fungals which includes nystatin mycelium. Characteristics: an amorphous powder. Application: the product is used as an intermediate for the extraction of nystatin and as feed-additive. Therapeutic category: polyene antibiotic with antifungal activi...

Nystatin powder

Centrient Pharmaceuticals provides wide range of anti-fungals which includes nystatin powder. Characteristics: a crystalline powder. Application: the product is suitable among others for the manufacture of creams, ointments, tablets and vaginal tablets after the addition of the appropriate excipients....

Oxacillin sodium compacted

Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes oxacillin sodium compacted. Characteristics: granules obtained by means of dry compaction of the crystalline powder without adding any excipients. Application: the product is suitable for the manufacture of capsules ...

Penicillin G potassium, non-sterile

Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the completion of the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”).

With the addition of Astral SteriTech’s Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin sterile injectable finished dosage forms to Centrient’s product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine.

Available Marketing Authorizations